Pediatric oncologists' practices of prescribing selective serotonin reuptake inhibitors (SSRIs) for children and adolescents with cancer: A multi-site study

Pediatric Blood and Cancer

Volumn 58, Issue 2, 2012, Pages 210-215

  Phipps, Sean ^a   Buckholdt, Kelly E ^a   Fernandez, Laly ^b   Wiener, Lori ^c   Kupst, Mary Jo ^d   Madan Swain, Avi ^e   Mullins, Larry ^f   Robert, Rhonda ^g   Sahler, Olle Jane ^h   Vincent, Nicole ⁱ   Noll, Robert B ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e University of Alabama at Birmingham   (United States)

^f OKLAHOMA STATE UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Antidepressants; Depression; FDA; Psychology; Supportive care

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ANXIETY DISORDER; ARTICLE; CANCER CENTER; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CONSULTATION; DEPRESSION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HEALTH PRACTITIONER; HUMAN; MEDICAL PRACTICE; MONITORING; PRESCRIPTION; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; SYMPTOM;

ADOLESCENT; CHILD; DEPRESSIVE DISORDER; DRUG PRESCRIPTIONS; GUIDELINE ADHERENCE; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; SEROTONIN UPTAKE INHIBITORS; SUICIDE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79960709131     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22788     Document Type: Article

References (21)

1. Patenaude AF, Kupst MJ. Psychosocial functioning in pediatric cancer. J Pediatr Psychol 2005;30:9-27.
2. Kazak AE. Evidence-based interventions for survivors of childhood cancer and their families. J Pediatr Psychol 2005;30:29-39.
3. Pao M, Ballard ED, Rosenstein DL, et al. Psychotropic medication use in pediataric patients with cancer. Arch Pediatr Adolesc Med 2006;160:818-822.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association; 1994.
5. Portteus A, Ahmad N, Tobey D, et al. The prevalence and use of antidepressant medication in pediatric cancer patients. J Child Adolesc Psychopharmacol 2006;16:467-473.
6. Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 2005;46:735-754.
7. Zito JM, Tobi H, deJong-van den Berg LT, et al. Antidepressant prevalence for youths: A multinational comparison. Pharmacoepidemiol Drug Saf 2006;15:793-798.
8. Canning EH, Canning RD, Boyce WT. Depressive symptoms and adaptive style in children with cancer. J Amer Acad Child Adolesc Psychiatry 1992;31:1120-1124.
9. Phipps S, Srivastava DK. Repressive adaptation in children with cancer. Health Psychol 1997;16:521-528.
10. Phipps S, Srivastava DK. Approaches to the measurement of depressive symptomatology in children with cancer: Attempting to circumvent the effects of defensiveness. J Dev Behav Pediatr 1999;20:150-155.
11. Noll RB, Gartstein MA, Vannatta K, et al. Social, emotional, and behavioral functioning of children with cancer. Pediatrics 1999;103:71-78.
12. DeJong M, Frombonne E. Depression in paediatric cancer: An overview. Psycho-onology 2006;15:553-566.
13. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A metaanalysis of randomized controlled trials. JAMA 2007;297:1683-1696.
14. Hetrick S, Merry S, McKenzie J, et al. Selective serotoning reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007;18:CD004851.
15. Kersun LS, Elia J. Review: Depressive symptoms and SSRI use in pediatric oncology patients. Pediatr Blood Cancer 2007;49:881-887.
16. Kersun LS, Kazak AK. Prescribing practices of selective serotonin reuptake inhibitors (SSRIs) among pediatric oncologists: A single institution experience. Pediatr Blood Cancer 2006;47:339.
17. Noll RB, Kupst MJ. The psychological impact of pediatric cancer: Hardiness, the exception or the rule? J Pediatr Psychol 2007;32:1089-1098.
18. Phipps S. Adaptive style in children with cancer: Implications for a positive psychology approach. J Pediatr Psychol 2007;32:1055-1066.
19. Kirsch I, Sapirstein G. Listening to prozac but hearing placebo: A meta-analysis of antidepressant medications. In: Kirsch I, editor. How expectancies shape experience. Washington, DC: American Psychological Association; 1999. pp. 303-320.
20. Kennard BD, Emslie GJ, Mayes TL, et al. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry 2008;47:1395-1404.
21. Mitchell AJ. Short screening tools for cancer-related distress: A review and diagnostic validity meta-analysis. J Natl Compr Canc Netw 2010;8:487-494.